Nanotetrac Targets Integrin Αvβ3 on Tumor Cells to Disorder Cell Defense Pathways and Block Angiogenesis
OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s67393
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2014
Authors
Publisher
Informa UK Limited